This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Vyome Biosciennces Pvt. Ltd., Vyome Therapeutics Limited. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Suresh Rameshlal Chawrai: Innovator in Acne Treatment
Introduction
Suresh Rameshlal Chawrai is a notable inventor based in Pune, India. He has made significant contributions to the field of medical treatments, particularly focusing on bacterial infections and antibiotic resistance. With a total of 2 patents, his work is paving the way for innovative solutions in healthcare.
Latest Patents
Chawrai's latest patents include groundbreaking treatments for resistant acne. The present disclosure relates generally to novel molecules, compositions, and formulations for the treatment of bacterial infections, specifically targeting infections caused by antibiotic-resistant pathogens. This innovative approach aims to provide effective solutions for patients suffering from resistant acne.
Career Highlights
Throughout his career, Suresh Rameshlal Chawrai has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Vyome Biosciences Pvt. Ltd. and Vyome Therapeutics Limited. His experience in these organizations has contributed to his expertise in developing novel therapeutic solutions.
Collaborations
Chawrai has collaborated with esteemed professionals in the field, including Shiladitya Sengupta and Shamik Ghosh. These collaborations have further enhanced his research and development efforts, leading to innovative advancements in acne treatment.
Conclusion
Suresh Rameshlal Chawrai is a dedicated inventor whose work in developing treatments for resistant acne is making a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile